TPHA TEST

The Treponema pallidum hemagglutination (TPHA) test, a pivotal diagnostic offering from Hypro Diagnostics, plays a crucial role in identifying antibodies in a patient’s serum sample against the causative agents of syphilis. Employing the hemagglutination method, this test is specifically adept at detecting Palladium antibodies associated with syphilis infection. In the procedure, red blood cells are sensitized with T. palladium fragments. When introduced to a serum sample infected with syphilis, these cells form aggregates on the surface of the test dish. The unique aggregation pattern serves as a distinct indicator, allowing healthcare professionals at Hypro Diagnostics to precisely assess the presence and concentration of syphilis-related antibodies in the patient’s bloodstream. The TPHA test, with its diagnostic accuracy, is instrumental in ensuring the timely and targeted intervention necessary for effective patient management and the control of syphilis infections.